QuidelOrtho Corporation (QDEL)

NASDAQ: QDEL · Real-Time Price · USD

13.59

-0.18 (-1.31%)

At close: Oct 27, 2026, 4:00 PM EDT

13.58

-0.01 (-0.07%)

Pre-market: Oct 28, 2026, 8:21 AM EDT

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Jun '26 Jun 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 2, 2022	Jan '21 Jan 3, 2021	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Labs Revenue	1.50B	1.51B	1.43B
Immunohematology Revenue	555.50M	543.80M	522.00M
Donor Screening Revenue	38.30M	52.60M	115.10M
Transfusion Medicine Revenue	593.80M	596.40M	637.10M
Point of Care Revenue	558.70M	601.60M	694.60M
Molecular Diagnostics Revenue	22.70M	26.50M	24.00M
Revenue (Total)	2.67B	-	-

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Jun '26 Jun 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 2, 2022	Jan '21 Jan 3, 2021	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
North America Adjusted EBITDA	752.00M	807.00M	892.10M
EMEA Adjusted EBITDA	90.00M	82.60M	46.50M
China Adjusted EBITDA	120.20M	141.20M	130.50M
JPAC Adjusted EBITDA	-	73.20M	69.90M
Latin America Adjusted EBITDA	-	78.40M	63.60M
Other Geographies Adjusted EBITDA	154.40M	151.60M	133.50M
Corporate Adjusted EBITDA	-596.70M	-585.40M	-659.70M
Operating Income (Total)	-824.70M	-	-